AIDS Clinical Center, The National Center for Global Health and Medicine, Tokyo, Japan.
Department of Clinical Laboratory Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Sci Rep. 2023 May 23;13(1):8322. doi: 10.1038/s41598-023-35171-y.
Although infection with the methicillin-resistant Staphylococcus aureus (MRSA) clone USA300 is extremely rare in Japan, the uniquely evolved clone ΨUSA300 has been reported in Japan. An outbreak of a distinct USA300 clone was recently reported in an HIV/AIDS referral hospital in Tokyo. The present study investigated the evolutionary origin and genetic diversity of USA300-related clones causing regional outbreaks among people living with HIV (PLWHIV) in Tokyo. MRSA isolates collected from PLWHIV in an HIV/AIDS referral center in Tokyo were subjected to whole-genome sequencing and their genetic features were compared with those of previously described USA300 MRSA genomes. Of the 28 MRSAs isolated in 2016-2019, 23 (82.1%) were identified as USA300, with 22 (95.6%) of the latter identified as ΨUSA300. Although the genomic structure of ΨUSA300 was identical to the structures of reference USA300 strains, one clade (cluster A) was found to have acquired 29 previously identified lineage-specific mutations in a stepwise manner. The estimated divergence dates of ΨUSA300 and Cluster A were 2009 and 2012, respectively. These findings suggested that the ΨUSA300 clone had spread among PLWHIVs in Tokyo in the early 2010s, with stepwise acquisition of lineage-specific nonsynonymous mutations.
尽管耐甲氧西林金黄色葡萄球菌(MRSA)USA300 克隆在日本极为罕见,但已在日本报道了独特进化的克隆 ΨUSA300。最近,在东京的一家艾滋病病毒/艾滋病转诊医院报告了一次独特的 USA300 克隆爆发。本研究调查了导致东京 HIV 感染者(PLWHIV)区域性爆发的与 USA300 相关克隆的进化起源和遗传多样性。对来自东京一家艾滋病病毒/艾滋病转诊中心的 PLWHIV 中分离出的 MRSA 进行全基因组测序,并将其遗传特征与先前描述的 USA300 MRSA 基因组进行比较。在 2016-2019 年分离的 28 株 MRSAs 中,23 株(82.1%)被鉴定为 USA300,其中 22 株(95.6%)被鉴定为 ΨUSA300。尽管 ΨUSA300 的基因组结构与参考 USA300 株的结构完全相同,但发现一个分支(A 群)以逐步的方式获得了 29 个先前鉴定的谱系特异性突变。ΨUSA300 和 A 群的估计分歧日期分别为 2009 年和 2012 年。这些发现表明,ΨUSA300 克隆在 21 世纪 10 年代初期在东京的 PLWHIV 中传播,并逐步获得谱系特异性非同义突变。